The newly merged university opened its $100 million Center for Brain Health and is making strides in treatment of Alzheimer's.

In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found ...

The anguish isn't over lost memories, but losing the people we love while still alive. The cruelest Alzheimer's symptom is ...

Boosting levels of a certain molecule that declines with age was found to restore memory and brain function in Alzheimer’s ...

A study published Wednesday reports "significant" disparities in the risk of dementia for lower income and non-white ...

Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.

Researchers have identified special immune cells in the brain that help slow Alzheimer’s. These microglia work to reduce inflammation and block the spread of harmful proteins. They appear to protect ...

Scientists have discovered a new target in the brain that could help prevent Alzheimer’s patients from losing memories of ...